[PDF][PDF] Obesity protects cancer from drugs targeting blood vessels
Y Cao - Cell Metabolism, 2018 - cell.com
Cell Metabolism, 2018•cell.com
Drugs that target angiogenesis are commonly used for treating various cancers, but their
clinical benefits are limited. In a recent Science Translational Medicine article, Incio et
al.(2018) provide mechanistic insight on the role of obesity in the development of anti-VEGF
drug resistance in human patients and murine models of breast cancer.
clinical benefits are limited. In a recent Science Translational Medicine article, Incio et
al.(2018) provide mechanistic insight on the role of obesity in the development of anti-VEGF
drug resistance in human patients and murine models of breast cancer.
Drugs that target angiogenesis are commonly used for treating various cancers, but their clinical benefits are limited. In a recent Science Translational Medicine article, Incio et al. (2018) provide mechanistic insight on the role of obesity in the development of anti-VEGF drug resistance in human patients and murine models of breast cancer.
cell.com